Oxford Biomedica

At OXB, we're always evolving to better serve our clients worldwide. As part of this growth, our 𝗟𝘆𝗼𝗻 𝘀𝗶𝘁𝗲 𝗶𝘀 𝗻𝗼𝘄 𝗳𝘂𝗹𝗹𝘆 𝗲𝗾𝘂𝗶𝗽𝗽𝗲𝗱 𝗳𝗼𝗿 𝗟𝗲𝗻𝘁𝗶𝘃𝗶𝗿𝗮𝗹 𝘃𝗲𝗰𝘁𝗼𝗿 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴, strengthening our ability to serve clients across Europe alongside our UK and US sites. With the Lentivirus process now available in France, we’re even better positioned to meet growing demand and advance life-changing therapies. This milestone reflects the dedication and collaboration of our teams, whose expertise keeps us at the forefront of innovation and client-focused excellence. Learn more about our expanding global reach: https://lnkd.in/eXCSfTtU #LentiviralVector #ViralVectors #AdvancedTherapies #CellandGeneTherapy #OXBInnovation #CDMO #OXB

2025 is shaping up to be a big year for advanced therapies. What do you think will have the biggest impact? 𝗦𝗵𝗮𝗿𝗲 𝘆𝗼𝘂𝗿 𝗽𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗽𝗼𝗹𝗹 𝗮𝗻𝗱 𝘁𝗲𝗹𝗹 𝘂𝘀 𝘄𝗵𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗰𝗼𝗺𝗺𝗲𝗻𝘁𝘀—we’ll check back in a year and see who was right! #FutureOfMedicine #CellandGeneTherapy #AdvancedTherapies #OXB #CDMO 

We were delighted to take part in 𝗖𝗮𝗿𝗲𝗲𝗿𝘀 𝗙𝗲𝘀𝘁 𝟮𝟬𝟮𝟱, hosted by OxLEP Skills Hub's Oxfordshire Career Hub, where we met thousands of students eager to learn about different career paths, including those in science and biotech. From learning how scientists maintain a sterile lab environment to mastering pipetting techniques, students got hands-on experience with some essential industry skills—while also discovering the many career opportunities available at OXB. A huge thank you to OxLEP Skills Hub for organising such a fantastic event, and to all the students who stopped by our stand—we loved sharing our work with you! #CareersFest2025 #STEMCareers #CellandGeneTherapy #AdvancedTherapies #TeamOXB #CDMO #OXB  

At OXB, work isn’t just about what we do—it’s about who we do it with. We’re committed to creating a culture where people feel supported, valued, and able to grow. That’s why recognition like being named on the Financial Times UK’s Best Employers list is so meaningful, it reflects the environment we’ve built together. Hear from our Chief People Officer, Lisa Doman, on what makes OXB a great place to work below. We’re proud of this recognition, but we know there’s always room to grow. 𝗪𝗵𝗮𝘁 𝗱𝗼 𝘆𝗼𝘂 𝘁𝗵𝗶𝗻𝗸 𝗺𝗮𝗸𝗲𝘀 𝗮 𝘄𝗼𝗿𝗸𝗽𝗹𝗮𝗰𝗲 𝘁𝗿𝘂𝗹𝘆 𝗴𝗿𝗲𝗮𝘁? 𝗟𝗲𝘁 𝘂𝘀 𝗸𝗻𝗼𝘄 𝗶𝗻 𝘁𝗵𝗲 𝗰𝗼𝗺𝗺𝗲𝗻𝘁𝘀 👇   #FTBestEmployers #UKBestCompanies #OXB #LifeAtOXB #CellandGeneTherapy #AdvancedTherapies #CDMO #OXB

Some good news to head into the weekend with—a remarkable step forward for gene therapy. Tomas, a baby diagnosed with OTC deficiency, was facing the prospect of a liver transplant until he was enrolled on the OTC-HOPE trial, a groundbreaking gene therapy trial at Great Ormond Street Hospital. Six months later, he no longer needs scavenger medications or a restricted diet, offering real hope for families facing this rare metabolic disorder.    Stories like this remind us why innovation in gene therapy matters—not just in theory, but in the lives of real patients.    Read more about Tomas’s story here: https://lnkd.in/eWphuUVH #CellAndGeneTherapy #AdvancedTherapies #Innovation #PatientImpact #OXB #CDMO

𝗔 𝗯𝗶𝗴 𝗻𝗶𝗴𝗵𝘁 𝗶𝗻 𝘁𝗵𝗲 𝗕𝗶𝗴 𝗔𝗽𝗽𝗹𝗲! 🏆 Our Chief Business Officer, Sébastien Ribault, and Head of Business Development, Sharmilee Patel, attended the 𝟮𝟬𝟮𝟱 𝗖𝗗𝗠𝗢 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 𝗔𝘄𝗮𝗿𝗱𝘀 𝗰𝗲𝗿𝗲𝗺𝗼𝗻𝘆 in New York last night to accept our 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 – 𝗚𝗹𝗼𝗯𝗮𝗹 𝗖𝗮𝘁𝗲𝗴𝗼𝗿𝘆 𝘄𝗶𝗻! This recognition, driven by client feedback, is a testament to the unwavering dedication of our teams across the UK, US, and France to provide best-in-class pure-play CDMO services.    A huge thank you to Outsourced Pharma, Life Science Connect, and Orientation Marketing for organising such a fantastic event, and to the sponsors Federal Equipment Company, MasterControl, and Ecolab Life Sciences for their support. Most of all, thank you to our clients for your trust—we’re proud to stand alongside you in shaping the future of advanced therapies.    Here’s to continued innovation, collaboration, and delivering life-changing therapies together!    #CDMOLeadershipAwards #CellandGeneTherapy #AdvancedTherapies #OXBWins #CDMO #OXB

𝗟𝗶𝘃𝗲 𝗳𝗿𝗼𝗺 Advanced Therapies Congress 𝗮𝘁 𝗘𝘅𝗖𝗲𝗟 𝗟𝗼𝗻𝗱𝗼𝗻! Day 1 is off to a busy start—catching up with familiar faces, meeting new ones and having some great discussions on the future of viral vector manufacturing. It’s inspiring to see so many people passionate about advancing cell and gene therapy! If you’re here today or tomorrow, come say hi at 𝗯𝗼𝗼𝘁𝗵 𝟭𝟯𝟴—let’s chat about how OXB can help move your therapy forward. #AdvancedTherapiesCongress #AdvancedTherapies #CellandGeneTherapy #MeetOXB #CDMO #OXB

Join us at BioProcess International 𝗨𝗦 𝗪𝗲𝘀𝘁 𝗳𝗿𝗼𝗺 𝗠𝗮𝗿𝗰𝗵 𝟭𝟴-𝟮𝟭 in San Diego!☀️   Looking for tailored viral vector solutions to accelerate your therapy? OXB's Konstantin Kazarian, PhD, will be there to discuss how we can support your project’s success.    Reach out to Konstantin Kazarian, PhD directly or email us at partnering@oxb.com to connect.    #BPIWest #CellandGeneTherapy #AdvancedTherapies #MeetOXB #CDMO #OXB 

Next stop: London! 𝗢𝗫𝗕 𝗶𝘀 𝗵𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 𝘁𝗵𝗲 Advanced Therapies Congress 𝗼𝗻 𝗠𝗮𝗿𝗰𝗵 𝟭𝟴-𝟭𝟵. 𝗩𝗶𝘀𝗶𝘁 𝘂𝘀 𝗮𝘁 𝗯𝗼𝗼𝘁𝗵 #𝟭𝟯𝟴 to meet Sandrine Lopes and Loriane Dhaussy and discover how OXB's expertise in viral vector manufacturing can accelerate your project. Plus, don’t miss our scientific poster! On day 2 at 10:50 AM, Maria Kapanidou, will be presenting her latest research on advanced nuclease applications for improved downstream recovery and vector quality. Looking forward to connecting in London! #AdvancedTherapiesCongress #AdvancedTherapies #CellandGeneTherapy #MeetOXB #CDMO #OXB 

We’re heading to Milan! 𝗝𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝗕𝗜𝗢-𝗘𝘂𝗿𝗼𝗽𝗲 𝗦𝗽𝗿𝗶𝗻𝗴 𝗳𝗿𝗼𝗺 𝗠𝗮𝗿𝗰𝗵 𝟭𝟳-𝟭𝟵.   Our Business Development Director, Edouard Weill, will be attending and is ready to connect. Whether you’re looking to explore strategic partnerships or discuss the latest in cell and gene therapy, let’s start the conversation.    𝗪𝗮𝗻𝘁 𝘁𝗼 𝘀𝗲𝘁 𝘂𝗽 𝗮 𝗺𝗲𝗲𝘁𝗶𝗻𝗴? Message Edouard Weill or reach out via 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝗶𝗻𝗴@𝗼𝘅𝗯.𝗰𝗼𝗺.    #BIOEuropeSpring #CellandGeneTherapy #AdvancedTherapies #MeetOXB #CDMO #OXB